Khalafalla Kareim, Ho Christopher Chee Kong, Chung Eric, Atmoko Widi, Shah Rupin, Agarwal Ashok
Department of Urology, Hamad Medical Corporation, Doha, Qatar.
Department of Urology, College of Medicine, Qatar University, Doha, Qatar.
Diagnostics (Basel). 2024 Oct 12;14(20):2275. doi: 10.3390/diagnostics14202275.
Vasectomy is a reliable male contraceptive method with a success rate exceeding 98%. Despite its efficacy, vasectomy is not foolproof, with potential early and late failures requiring careful postoperative monitoring via post-vasectomy semen analysis (PVSA). Published guidelines emphasize the necessity of conducting PVSA to ensure clinical sterility. Despite these clear guidelines, discrepancies in adherence and interpretation persist, with significant mismatches between guidelines and actual practice. Recent shifts in societal attitudes toward reproductive autonomy, spurred by significant political events and socioeconomic factors, have increased vasectomy rates, particularly among younger, childless men. This demographic change calls for enhanced PVSA compliance and clear communication about the non-immediate contraceptive effect of vasectomy. Home test kits have emerged as a convenient, though not always reliable, method for conducting PVSAs, which may require reevaluation in clinical practice. Given the variations across clinical guidelines and the challenges in achieving consistent PVSA outcomes, further research is needed to harmonize PVSA protocols across different health systems. PVSA is typically conducted between 8 and 16 weeks post-vasectomy, depending on the surgeon's preference. Success is confirmed when a fresh, uncentrifuged sample exhibits either azoospermia, rare non-motile sperm (RNMS), or fewer than 100,000 non-motile sperm per milliliter. This effort will ensure that both patients and practitioners can rely on vasectomy as a safe and effective form of contraception. Effective patient counseling and strategic follow-up are crucial when it comes to managing expectations and ensuring compliance with post-vasectomy protocols, thereby minimizing the risk of unintended pregnancies post-procedure.
输精管结扎术是一种可靠的男性避孕方法,成功率超过98%。尽管其有效性,但输精管结扎术并非万无一失,早期和晚期都可能出现失败情况,因此需要通过输精管结扎术后精液分析(PVSA)进行仔细的术后监测。已发布的指南强调进行PVSA以确保临床绝育的必要性。尽管有这些明确的指南,但在遵循和解释方面仍存在差异,指南与实际做法之间存在重大不匹配。近期,受重大政治事件和社会经济因素推动,社会对生殖自主权的态度发生转变,输精管结扎率有所上升,尤其是在年轻、无子女的男性中。这种人口结构变化要求提高PVSA的依从性,并就输精管结扎术的非即时避孕效果进行清晰沟通。家庭检测试剂盒已成为进行PVSA的一种方便但并非总是可靠的方法,在临床实践中可能需要重新评估。鉴于临床指南存在差异以及实现一致的PVSA结果面临挑战,需要进一步研究以统一不同卫生系统的PVSA方案。PVSA通常在输精管结扎术后8至16周进行,具体时间取决于外科医生的偏好。当新鲜、未离心的样本显示无精子症、罕见的非活动精子(RNMS)或每毫升非活动精子少于100,000个时,即为成功。这将确保患者和从业者都能依赖输精管结扎术作为一种安全有效的避孕方式。在管理期望和确保遵循输精管结扎术后方案方面,有效的患者咨询和策略性随访至关重要,从而将术后意外怀孕的风险降至最低。